Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Funding to support clinical advancement of SAB-142, a potential disease-modifying treatment Financing led by RA Capital Management, with participation from BVF Partners, Sessa Capital, Commodore...
Commodore Capital LP lifted its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 24.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 575,000 shares of the biotechnology company’s stock after purchasing an additional 112,889 shares during the quarter. […]
Commodore Capital LP raised its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 47.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 790,000 shares of the company’s stock after purchasing an additional 252,924 shares during the quarter. Akero Therapeutics accounts […]
Commodore Capital LP boosted its position in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 8.4% in the 1st quarter, HoldingsChannel reports. The fund owned 2,189,659 shares of the company’s stock after acquiring an additional 169,493 shares during the period. Viridian Therapeutics accounts for about 8.5% of Commodore Capital LP’s portfolio, making the […]
Commodore Capital LP lifted its position in shares of Merus (NASDAQ:MRUS – Free Report) by 8.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,950,000 shares of the biotechnology company’s stock after acquiring an additional 217,433 shares during the […]